Mark A. Wilson

Chief Legal Officer @ Nektar Therapeutics arrow icon

About Mark A. Wilson

Mark A. Wilson is the Chief Legal Officer with a background in pharmacy and law, specializing in patent law and registered to practice before the U.S. Patent and Trademark Office.

Known information

Mark A. Wilson serves as the Chief Legal Officer, holding a Juris Doctor degree from Seton Hall University, School of Law, and a Bachelor of Science in pharmacy from Rutgers University, College of Pharmacy. He is registered to practice before the U.S. Patent and Trademark Office and is a member of the California Bar. Prior to his current role, Wilson worked as an associate at Reed & Associates, a patent law firm based in Menlo Park, California, where he gained substantial experience in handling legal matters related to patents.

About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company focused on developing novel therapies that modulate the immune system to treat autoimmune disorders, chronic inflammatory conditions, and cancer.

report flag Report inaccurate information

People similar to Mark A. Wilson

Howard W. Robin

President & Chief Executive Officer @ Nektar Therapeutics

Howard W. Robin is the President and CEO of Nektar Therapeutics, with over 25 years of experience in biopharmaceutical clinical development and commercial operations.

Sandra Gardiner

Chief Financial Officer @ Nektar Therapeutics

Sandra Gardiner is a seasoned business and finance executive with over 30 years of experience, currently serving as CFO and Partner at FLG Partners and previously holding multiple CFO roles in global companies.

Jennifer Ruddock is the Chief Business Officer at Nektar, responsible for multiple corporate functions and has extensive experience in investor relations and corporate marketing.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free